{"id":390509,"date":"2018-12-24T00:00:00","date_gmt":"2018-12-24T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/dlsfon0001-2018-biopharma-breast-cancer-disease-landscape-and-forecast-g7-2018\/"},"modified":"2026-04-14T10:26:07","modified_gmt":"2026-04-14T10:26:07","slug":"dlsfon0001-2018-biopharma-breast-cancer-disease-landscape-and-forecast-g7-2018","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/dlsfon0001-2018-biopharma-breast-cancer-disease-landscape-and-forecast-g7-2018\/","title":{"rendered":"Breast Cancer | Disease Landscape and Forecast | G7 | 2018"},"content":{"rendered":"<p><b>Market Outlook<\/b><\/p>\n<p>Characterized by high incidence and long treatment durations, the breast cancer market represents a great commercial opportunity for drug developers.\u00a0<abbr title=\"cyclin-dependent kinase 4\">CDK4<\/abbr>\/6 inhibitors (Pfizer\u2019s Ibrance, Novartis Kisqali and Eli Lilly\u2019s Verzenio) are creating new dynamics in the metastatic\u00a0<abbr title=\"hormone receptor\">HR<\/abbr>+\/<abbr title=\"human epidermal growth factor receptor-2\">HER2<\/abbr>\u2013 treatment practice. In\u00a0<abbr title=\"human epidermal growth factor receptor-2\">HER2<\/abbr>+ breast cancer, emerging\u00a0<abbr title=\"human epidermal growth factor receptor-2\">HER2<\/abbr>-targeting drugs currently in development are forecasted to enter the market, while current\u00a0<abbr title=\"human epidermal growth factor receptor-2\">HER2<\/abbr>-targeting agents see their sales changing as a result of competition, label expansions, biosimilars entry and new trials leading to changes in treatment guidelines. Furthermore, the approval of AstraZeneca\u2019s Lynparza and anticipated future entry of other\u00a0<abbr title=\"poly ADP (adenosine diphosphate)-ribose polymerase\">PARP<\/abbr>\u00a0inhibitors and immune checkpoint inhibitors will provide more diverse treatment options, especially for triple-negative breast cancer.<\/p>\n<p><strong>Questions answered:<\/strong><\/p>\n<ul>\n<li>What is the size of the drug-treatable breast cancer population, and how will drug-treatment rates change over time?<\/li>\n<li>What is the expected market impact of recent drug approvals, such as AZ\u2019s Lynparza, or label extensions like Roche\/Genentech\u2019s Perjeta in the\u00a0<abbr title=\"human epidermal growth factor receptor-2\">HER2<\/abbr>\u00a0adjuvant setting or Eli Lilly\u2019s Verzenio in\u00a0<abbr title=\"hormone receptor\">HR<\/abbr>\u00a0first-line metastatic setting?<\/li>\n<li>What are the most promising agents in the pipeline, and how will they shape the future of the breast cancer market?<\/li>\n<li>What are the drivers and constraints in the breast cancer market, and how will the market evolve over the forecast period?<\/li>\n<\/ul>\n<p><strong>Product Description:<\/strong><\/p>\n<p>Disease Landscape &#038; Forecast provides comprehensive market intelligence with world-class epidemiology, keen insight into current treatment paradigms, in-depth pipeline assessments, and drug forecasts supported by detailed primary and secondary research.<\/p>\n","protected":false},"template":"","class_list":["post-390509","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-breast-cancer","biopharma-date-920"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390509","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390509\/revisions"}],"predecessor-version":[{"id":576661,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390509\/revisions\/576661"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=390509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}